Odyssey Investment Partners is in advanced negotiations to acquire Honeywell International Inc.'s personal protective equipment unit, potentially valuing the deal at $1.5 billion.
Odyssey Investment Partners is reportedly in advanced discussions to acquire Honeywell International Inc.'s personal protective equipment (PPE) unit, according to sources familiar with the matter. The deal, which could be announced in the coming weeks, is expected to value Honeywell's PPE unit at approximately $1.5 billion. This unit includes products such as respiratory protection, hearing aids, work boots, and face masks, which saw a surge in demand during the COVID-19 pandemic. However, demand has since waned as the pandemic subsided.
The potential acquisition aligns with Honeywell's strategic efforts to realign its business focus towards aerospace, energy transition, and automation systems. Honeywell's CEO, Vimal Kapur, has been actively working on reshaping the company's portfolio, which recently included plans to spin off its advanced materials business, projected to generate up to $3.9 billion in revenue for the 2024 fiscal year.
Odyssey, a private equity firm, has prior exposure to the PPE market through its acquisition of Protective Industrial Products from Audax Private Equity in 2020. The firm is finalizing the deal, although deliberations are ongoing and could still face delays or the emergence of other potential buyers.
Honeywell has been active in the acquisition space as well, having recently acquired Carrier Global Corp.'s security unit and Air Products' liquefied natural gas process technology and equipment business. Honeywell's shares rose by 1.1% to $215.99 in New York, reflecting a market value of about $140 billion.
Both Honeywell and Odyssey have declined to comment on the ongoing negotiations.
Party City, a leading retailer in the party supplies industry, has filed for bankruptcy and announced the closure of all its stores, marking the end of nearly 40 years in business.
Honda and Nissan are in talks for a potential merger to address financial struggles and enhance competitiveness in the electric vehicle market.
Google has proposed to loosen its search engine agreements with companies like Apple to address antitrust concerns, while the US government pushes for more drastic measures.
The US FDA has approved Novo Nordisk's Alhemo, a groundbreaking treatment for hemophilia A and B with inhibitors, marking a significant advancement in hemophilia care.
The US FDA has declined to approve Lexicon Pharmaceuticals' Zynquista as an add-on treatment for type 1 diabetes and chronic kidney disease, prompting the company to shift focus to other drug candidates.
Sarepta Therapeutics Inc. has secured a $115.2 million verdict against Nippon Shinyaku Co. Ltd. for patent infringement related to its Duchenne muscular dystrophy drug, Vyondys 53.
A US jury remains deadlocked in the high-stakes trial between Arm Holdings and Qualcomm over a licensing dispute involving Nuvia's chip designs, with deliberations ongoing.
Netflix has acquired the exclusive U.S. broadcasting rights for the FIFA Women's World Cup in 2027 and 2031, marking a significant move into live sports for the streaming giant.
Carnival Corporation & plc has reported record earnings for 2024, surpassing guidance and setting a positive outlook for 2025 with expected earnings growth and strong booking volumes.
United States Steel Corporation's stock has taken a hit following a weaker-than-expected fourth-quarter outlook, with projected losses and challenges in the steel market.